| Primary |
| Drug Use For Unknown Indication |
41.4% |
| Product Used For Unknown Indication |
7.6% |
| Latex Allergy |
5.5% |
| Gastric Ulcer |
4.8% |
| Induction Of Anaesthesia |
4.8% |
| Premedication |
4.1% |
| Abdominal Discomfort |
2.8% |
| Dyspepsia |
2.8% |
| Gastritis |
2.8% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Muscular Weakness |
2.8% |
| Obsessive-compulsive Disorder |
2.8% |
| Atrial Fibrillation |
2.1% |
| Cerebral Infarction |
2.1% |
| Constipation |
2.1% |
| Dystonia |
2.1% |
| Eczema |
2.1% |
| Gastric Cancer |
2.1% |
| Abdominal Pain Upper |
1.4% |
| Chest Pain |
1.4% |
|
| Drug Ineffective |
23.8% |
| Vomiting |
11.1% |
| Product Quality Issue |
4.8% |
| Rash Erythematous |
4.8% |
| Stomach Discomfort |
4.8% |
| Therapeutic Response Unexpected |
4.8% |
| Vision Blurred |
4.8% |
| Alopecia |
3.2% |
| Breast Enlargement |
3.2% |
| Drug Administration Error |
3.2% |
| Headache |
3.2% |
| Hepatitis Acute |
3.2% |
| Malaise |
3.2% |
| Myasthenia Gravis |
3.2% |
| Nervousness |
3.2% |
| Pyrexia |
3.2% |
| Rash |
3.2% |
| Reactive Psychosis |
3.2% |
| Renal Impairment |
3.2% |
| Stress |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
24.9% |
| Drug Use For Unknown Indication |
14.9% |
| Hypertension |
8.9% |
| Drug Exposure Via Mother |
6.7% |
| Lupus Nephritis |
5.8% |
| Latex Allergy |
4.8% |
| Premedication |
3.4% |
| Breast Cancer Metastatic |
2.9% |
| Gastric Ulcer |
2.9% |
| Spinal Anaesthesia |
2.9% |
| Third Stage Postpartum Haemorrhage |
2.9% |
| Depression |
2.4% |
| Induction Of Anaesthesia |
2.4% |
| Urticaria |
2.4% |
| Cholangitis |
2.2% |
| Headache |
2.2% |
| Gastritis |
1.9% |
| Hyperlipidaemia |
1.9% |
| Preoperative Care |
1.9% |
| Prophylaxis |
1.9% |
|
| Hepatic Function Abnormal |
12.2% |
| Brugada Syndrome |
9.5% |
| Toxic Epidermal Necrolysis |
9.5% |
| White Blood Cell Count Decreased |
9.5% |
| Drug Hypersensitivity |
8.1% |
| Abortion Missed |
5.4% |
| Vomiting |
5.4% |
| Wound |
5.4% |
| Pancreatic Disorder |
4.1% |
| Respiratory Disorder |
4.1% |
| Abnormal Behaviour |
2.7% |
| Anaphylactic Shock |
2.7% |
| Bradycardia |
2.7% |
| Convulsion |
2.7% |
| Dialysis |
2.7% |
| Drug Exposure During Pregnancy |
2.7% |
| Enterocolitis |
2.7% |
| Haemolytic Anaemia |
2.7% |
| Liver Disorder |
2.7% |
| Pancreatitis Acute |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.2% |
| Premedication |
9.1% |
| Hypertension |
8.8% |
| Gastrooesophageal Reflux Disease |
7.2% |
| Product Used For Unknown Indication |
6.7% |
| Prophylaxis |
6.6% |
| Rheumatoid Arthritis |
5.8% |
| Pain |
5.1% |
| Breast Cancer |
4.7% |
| Breast Cancer Metastatic |
3.7% |
| Osteoporosis |
3.4% |
| Gastritis |
3.4% |
| Non-small Cell Lung Cancer |
2.9% |
| Insomnia |
2.7% |
| Metastases To Bone |
2.7% |
| Depression |
2.4% |
| Nausea |
2.4% |
| Renal Transplant |
2.3% |
| Renal Cell Carcinoma Stage Iv |
2.3% |
| Ovarian Cancer |
1.9% |
|
| Vomiting |
13.9% |
| Weight Decreased |
11.8% |
| Rash |
9.8% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
6.5% |
| Vitamin D Deficiency |
4.9% |
| White Blood Cell Count Decreased |
4.7% |
| Wound Infection Staphylococcal |
4.5% |
| Pneumonia |
3.9% |
| Urticaria |
3.7% |
| Wound Treatment |
3.7% |
| Pleural Effusion |
3.5% |
| Respiratory Failure |
3.5% |
| Ventricular Extrasystoles |
3.5% |
| Interstitial Lung Disease |
3.3% |
| Myocardial Infarction |
3.3% |
| Pyrexia |
3.3% |
| Thrombocytopenia |
3.3% |
| Upper Respiratory Tract Inflammation |
3.3% |
| Wheezing |
3.1% |
| Nausea |
2.9% |
|
| Interacting |
| Obesity |
44.2% |
| Abdominal Pain |
9.6% |
| Diabetes Mellitus |
9.6% |
| Myocardial Ischaemia |
9.6% |
| Oedema |
9.6% |
| Abdominal Pain Upper |
5.8% |
| Duodenal Ulcer |
5.8% |
| Atrial Fibrillation |
3.8% |
| Type 2 Diabetes Mellitus |
1.9% |
|
| Renal Failure Acute |
55.6% |
| Vomiting |
33.3% |
| Pruritus |
11.1% |
|
